Safety and Effectiveness of Different Approaches for Epidural Steroid Injections in Lumbar Spinal Stenosis: A Systematic Review and Meta-Analysis.
Igor Wilderman, Francesca Sarzetto, Tina Didari...
https://pubmed.ncbi.nlm.nih.gov/42550520/Actively Recruiting
Led by Igor Wilderman. MD · Updated on 2026-08-13
500
Participants Needed
1
Research Sites
12 weeks
Total Duration
Researchers are evaluating the effectiveness and safety of various steroid injections for managing back pain, including injections at different locations like epidural, facet joints, and nerve blocks. The study compares different steroids, dosages, and combinations with local anesthetics to improve treatment guidelines for chronic spinal and sacro-iliac pain. This includes patients with lumbar canal stenosis, herniated discs, failed back surgery syndrome, and other spinal or joint-related pain conditions. The study has two parts a retrospective analysis and a prospective crossover design. It involves at least 100 patients per part receiving ultrasound-guided epidural steroid injections, facet joint, and sacroiliac joint injections, or local anesthetic injections. Different steroid types such as triamcinolone, methylprednisolone, betamethasone, and dexamethasone are compared. Oral low-dose naltrexone and lidocaine infusions are also studied in some patients. Participants provide pain and function ratings before and after injections at multiple time points up to 12 months. Researchers measure pain relief using numeric rating scales, integral of pain relief scores, and patient-reported outcome tools. They also track side effects, medication changes, bone density, and genetic factors affecting treatment response. Safety and efficacy are monitored throughout, with the study planned to complete by March 2030.
CONDITIONS
Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study)
I
Igor Wilderman, MD
F
Francesca Sarzetto, MD, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Igor Wilderman. MD
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months
Participants receive ultrasound-guided steroid or local anesthetic injections for back pain according to randomized assignments.
Multiple visits for injections and assessments at 2, 4, 6, 8, and 12 weeks, with possible follow-ups at 6 and 12 months
Duration - Up to 12 months
Participants complete pain and function assessments to evaluate long-term effects of the injections.
Assessments at 6 and 12 months if possible
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Igor Wilderman, Francesca Sarzetto, Tina Didari...
https://pubmed.ncbi.nlm.nih.gov/42550520/Igor Wilderman, Olga Zingerman, Francesca Sarzetto...
https://pubmed.ncbi.nlm.nih.gov/41404364/Igor Wilderman. MD
Lead Sponsor